Drug Approval | July 24, 2022
Dr. Reddy's announces the first-to-market, OTC launch of Allegra-D in the US market
Allegra-D had U.S. retail sales of approximately $45 million as of May 2022 according to IRI.
Allegra-D had U.S. retail sales of approximately $45 million as of May 2022 according to IRI.
Company raises the annual revenue guidance from mid-teens to high teens
The company now exceeds the sector benchmark for its overall ESG rating and for all three measures
Tobacco smoke increases infant morbidity and is fatal to a baby because it damages the baby’s organs
Strand Life Sciences has sequenced a total of 12800 samples from July, 2021 to June, 2022, and identified more than a 100 lineages circulating in Bengaluru
Upgrades and global expansion provide additional control, visibility, reliability and recovery for patient-critical, time-and temperature-sensitive products
Cellutions BioStorage is a comprehensive biomaterial storage and logistics company with a vision to leverage advanced technologies to serve biopharmaceutical companies
Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals
Syngene's collaboration with Zoetis started in 2011
This acquisition is in line with Cipla's strategic imperative to augment the company's wellness portfolio for bringing about a shift from an illness to a wellness mindset.
Subscribe To Our Newsletter & Stay Updated
